High-flow Nasal Cannula Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema
Summary
NIH has registered Clinical Trial NCT07536477, a randomized controlled study evaluating High-flow Nasal Cannula Oxygen Therapy (HFNC) versus Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE). The single-center trial plans to enroll 168 participants, with an estimated completion date of April 17, 2026. HFNC is the sole intervention under investigation.
What changed
This document records the registration of Clinical Trial NCT07536477 on ClinicalTrials.gov, describing a randomized study comparing High-flow Nasal Cannula Oxygen Therapy to conventional oxygen support for treating High-Altitude Pulmonary Edema. The trial specifies conditions (HAPE), interventions (HFNC), and participant count but does not establish new regulatory requirements.
Healthcare providers and medical device manufacturers involved in respiratory therapy should note this clinical investigation of HFNC efficacy for altitude-related pulmonary edema. While this registration does not impose compliance obligations, it reflects ongoing evaluation of oxygen delivery technologies that may inform future clinical practice guidelines and device submissions.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema
N/A NCT07536477 Kind: NA Apr 17, 2026
Abstract
This study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).
Conditions: High-altitude Pulmonary Edema
Interventions: High-flow Nasal Cannula Oxygen Therapy (HFNC)
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.